Cancer is less common in eastern Asia, where green tea is the most common beverage.
In April 2004 a study was published in the journal “Blood”, which shows that green tea has killing powers in the unpredictable and slow form of B cell leukemia. A component in green tea called epigallocatechin (EGCG) disturbs the chemical information flow in leukemia cells in lab cultures.
It means that the communication between the cells is disturbed, and cancer cells cannot multiply.
Dr. Neil Kay of the Mayo Clinic in Rochester, Minn. is confident that the compound EGCG will be of benefit especially in the treatment of early-stage patients.
In the meantime, a flavorful soothing cup of green tea has its benefits.
More info on leukemia: http://nethealthbook.com/cancer-overview/leukemia/
Based on National Review of Medicine (Canada), April 30,2004
Last edited October 26, 2014